Clinical Trial Data on TCM Fumigation and Suppository for Post-Hemorrhoidectomy Recovery

Haijing Zhao published a dataset on 2026-05-20 containing results from a prospective, stratified randomized controlled study of 160 patients. The data evaluates the efficacy and safety of traditional Chinese medicine fumigation combined with a Musk hemorrhoid suppository for recovery after Milligan-Morgan hemorrhoidectomy. It includes primary and secondary endpoints such as wound healing time, inflammatory markers, complication rates, and quality of life scores.

Use Cases

• Compare wound healing times across different postoperative treatment regimens based on the primary endpoint.
• Analyze the correlation between serum inflammatory factors (IL-6, TNF-α, CRP) and clinical outcomes based on the secondary endpoints.
• Model the impact of combined TCM therapy on patient quality of life scores (GQOL-30) mentioned in the description.
• Validate clinical trial findings using the internal validation cohort of 40 cases described in the methods.

Strengths

• Data is from a prospective, stratified randomized controlled trial with 160 patients and an internal validation cohort of 40 cases.
• Study design used Bonferroni correction for multiple comparisons to control Type I error, as stated in the methods.
• Results show specific, quantified outcomes, such as a wound healing time reduction of 2.30 days and a 4-week total effective rate of 97.50% for the combined treatment group.

Limitations

• Column-level documentation is absent; field semantics must be inferred after download.
• Row count is unknown, which may limit suitability assessment for specific analytical tasks.
• The 2.2 MB file size suggests a relatively small dataset, potentially limiting the scope for complex modeling.

Provenance

Source

Haijing Zhao via figshare

Collection Method

Prospective, stratified randomized controlled clinical trial.

Freshness

Last updated 2026-05-20 12:06:19; freshness should be verified.